DENTSPLY SIRONA Inc (XRAY) Expected to Post Quarterly Sales of $951.79 Million

Share on StockTwits

Equities analysts expect DENTSPLY SIRONA Inc (NASDAQ:XRAY) to post $951.79 million in sales for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have made estimates for DENTSPLY SIRONA’s earnings, with the highest sales estimate coming in at $1.02 billion and the lowest estimate coming in at $917.80 million. DENTSPLY SIRONA posted sales of $1.01 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 5.8%. The business is expected to report its next quarterly earnings results on Friday, November 2nd.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full-year sales of $3.99 billion for the current year, with estimates ranging from $3.95 billion to $4.13 billion. For the next fiscal year, analysts forecast that the company will report sales of $4.09 billion, with estimates ranging from $3.98 billion to $4.34 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.59 by $0.01. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. The firm had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the firm earned $0.65 earnings per share.

XRAY has been the topic of several research analyst reports. Jefferies Financial Group reduced their target price on DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, August 8th. Stifel Nicolaus reduced their price target on DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, August 8th. Goldman Sachs Group raised DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price target on the stock in a research note on Friday. TheStreet cut DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research note on Tuesday, August 14th. Finally, Barclays reduced their price target on DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 8th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $51.50.

A number of institutional investors have recently added to or reduced their stakes in XRAY. UBS Group AG boosted its holdings in DENTSPLY SIRONA by 15.4% in the first quarter. UBS Group AG now owns 201,617 shares of the medical instruments supplier’s stock worth $10,143,000 after acquiring an additional 26,951 shares in the last quarter. A.R.T. Advisors LLC boosted its holdings in DENTSPLY SIRONA by 329.7% in the first quarter. A.R.T. Advisors LLC now owns 31,800 shares of the medical instruments supplier’s stock worth $1,599,000 after acquiring an additional 24,400 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in DENTSPLY SIRONA by 3.5% in the first quarter. The Manufacturers Life Insurance Company now owns 328,361 shares of the medical instruments supplier’s stock worth $16,521,000 after acquiring an additional 10,959 shares in the last quarter. Natixis bought a new stake in DENTSPLY SIRONA in the first quarter worth $3,768,000. Finally, LPL Financial LLC boosted its holdings in DENTSPLY SIRONA by 12.3% in the first quarter. LPL Financial LLC now owns 47,484 shares of the medical instruments supplier’s stock worth $2,389,000 after acquiring an additional 5,201 shares in the last quarter. 97.56% of the stock is currently owned by institutional investors and hedge funds.

Shares of XRAY traded up $0.61 during mid-day trading on Wednesday, hitting $36.28. 4,193,512 shares of the company’s stock traded hands, compared to its average volume of 2,566,803. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.10 and a current ratio of 1.69. DENTSPLY SIRONA has a 1 year low of $35.30 and a 1 year high of $68.98. The stock has a market capitalization of $7.93 billion, a PE ratio of 13.64, a price-to-earnings-growth ratio of 2.07 and a beta of 1.20.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: What are the most popular ETFs

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analysts Anticipate Kindred Biosciences Inc  to Post -$0.42 Earnings Per Share
Analysts Anticipate Kindred Biosciences Inc to Post -$0.42 Earnings Per Share
Octoin Coin  Price Tops $0.63 on Top Exchanges
Octoin Coin Price Tops $0.63 on Top Exchanges
Signatum  Price Tops $0.0004
Signatum Price Tops $0.0004
Analysts Expect Shutterfly, Inc.  Will Post Earnings of $5.42 Per Share
Analysts Expect Shutterfly, Inc. Will Post Earnings of $5.42 Per Share
netBit  Market Capitalization Achieves $0.00
netBit Market Capitalization Achieves $0.00
PlexCoin Achieves Market Cap of $0.00
PlexCoin Achieves Market Cap of $0.00


© 2006-2018 Ticker Report